Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma

NCT01394939 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Carcinoma
CRC

Interventions

BIOLOGICAL: JX-594
DRUG: Irinotecan

Sponsor

Jennerex Biotherapeutics

Collaborators

[object Object]